Cited by: 107 1 Like researcher6076 April 28, 2026, 5:15am #3 FWIW, I do not think FOXO4-DRI has been used in ANY human trials, not Phase 1, not Phase 2, not observational cohorts
In controlled laboratory settings, this combination is widely utilised to examine connective tissue signalling, vascular response mechanisms, and coordinated recovery-related pathway activity
Developmental BPA exposure can also target sensory systems, leading to malformed otoliths 67 , inhibited regeneration of lateral line neuromasts 68 , reduced responses to green and red light 25 , and reduced habituation and prepulse inhibition in response to an auditory startle stimulus 69
As this molecule loses energy to come back to the ground state, it can transfer that energy to another molecule in its vicinity